Parmax Pharma: Rupa Sunil Shah Acquires 1.43% Stake

Rupa Sunil Shah, identified as PAC 5, has acquired 53,520 equity shares, representing 1.43% of the total share capital, in Parmax Pharma Limited through an off-market transaction on June 16, 2026. This acquisition was made in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Following this transaction, the total shareholding of the acquirer and PACs has increased to 768,320 shares, constituting 20.54% of the company's total equity.